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Summary: Several investigators haye reported recently that in rats, oral calcium load is associated with a
marked ameliöration in gentamicin-induced renal failure. In contrast to these reports, using the same animal
model, we could not observe calcium-induced moderation in gentamicin nephrotoxicity äs reflected by either
urea or creatinine serum cöncentration or by various renal cortical intracellular enzymatic activities. Similarly,
verapamil, a calcium channel blocker, had no effect on the degree of renal failure in these animals. We
conclüde that maniptilätion of calcium diet may not be uniformly effective in reducing gentamicin nephro-
toxicity. Additional nutritional factors may play a crucial role in achieving the ameliöration of this model of
toxic nephropathy.
Introduction . . .membrane (4). Another aspect of calcium metabohsm
Nephrotoxicity düe to aininoglycoside treatment is a in uraemia, namely nephrocalcinosis, was recently
known clinical complication (1). Lietman et al. (2) investigated by Goligorsky et al. (7), who found that
showed a fall in creatiiiine clearance in 15% of 214 verapamil prevents renal accumulation of calcium in
patients treated with aminpglycosides. Factors that ufaemic rats.
can reduce nephrotoxicity are of great importance äs
they may enäble the use of aniinoglycosides with The aim of the present study was:
minimal adverse efifects (3). In the last decade several tQ jnvesti the effeet of caldum loadi on the
investigators have demo^strated that dietary calcmm m^ rf tamicin.induced renal faüure and its
supplementation ameliorated gentamicin-mduced on varfous intracdlular renal cortical e
renal failure (4—6). The protectrve mechamsm was .
attributed, at least in part, to a calcium-mediated '
competitive Inhibition of gentamicin binding and up- b) to evaluate the effects of verapamil on this model
take along the renal proximal tubular brush border of toxic nephropathy.
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Materials and Methods
Male Sprague Dawley rats 6-8 week old, vveighing 150-200 g
were used for all studies. Animals vvere divided into six groups
(tab. 1).
Each group consisted of at least 12 animals. After 10 days all
rats vvere sacrificed. Blood for the various examinations was
drawn from the aorta. The serum was analysed for creatinine,
calcium, phosphorus and magnesium concentration. The kid-
neys were removed and processed for biochemical analysis. The
renal cortex was placed in a 0.02 mol/1 Tris HC1, pH 7.4 buffer
(l :10 weight to volume ratio) and homogenized in a Potter-
Elvehjem Glass Teflon homogenizer at 0-4°C. The homoge-
nate was centrifuged in a Sorvall RC 2B centrifuge at 0-4 °C
and the various cellular constituents were obtained by using
different centrifugal speeds according to a procedure previously
described (8).
Enzyme assays
Aspartate aminotransferase (EC 2.6.1.1), alanine aminotrans-
ferase (EC 2.6.1.2), L-iditol dehydrogenase (EC 1.1.1.14) and
orthophosphoric-monoester phosphohydrolase (alkaline opti-
mum) (EC 3.1.3.1) of the homogenate and serum were measured
spectrophotometrically with a Gilford Autoanalyser at 30 °C
by methods previously described (8, 9). Details of reaction and
performance characteristics (within run and run to run) are
given (10). Protein content was determined according to Lowry
et al. (11) Urea was determined enzymatically, accordirig to
Talke & Schubert (12) and creatinine according to Fabiny &
Ertingshausen (13). The gentamicin bioassay described by Ben-
net et al. (14) was performed with Muller Hinton Agar plates
at pH 8.0, using Bacillus subtilis strain AATC 6633; the ana-
lytical r nge was 0.05-3 mg/1 with CV < 2.0% at 1.5 mg/1.
Statistical analysis was performed using Studenfs t test and
also by analysis of variance. The results are given in mean
± S. E. M.
Tab. 1. Experimental design.
Results
Mean urea and creatinine concentrations were similar
in the control (Group 1), high ealcium diet (Group 3)
or verapamil treated (Group 5) rats. The administra-
tion of gentamicin resulted in severe renal failure s
manifested by the significant increase in serum urea
and creatinine concentrations. Neither oral ealcium
load nor verapamil had any significant attenuating
effect on the degree of renal failure (tab. 2).
Mean activities of sorbitol dehydrogenase, alkaline
phosphatase, aspartate aminotransferase and alanine
aminotransferase in renal tissue were similar in groups
l, 3 and 5. Treatment with gentamicin was associated
with a significant reduction in the activities of these
enzymes. The addition of ealcium or verapamil did
not result in any appreciable attenuation in genta-
micin-induced nephrotoxicity (tab. 3).
The relationship between serum urea and creatinine
(bpth reliable markers of glomerulaf filtration rate)
and cellular enzyme activities was investigated. Both
ser m urea and creatinine showed highly significant
inverse correlations with the activities of cellular as^
partate aminotransferase, alanine aminotransferase,
sorbitol dehydrogenase, alkaline phosphatase and lac-
tate dehydrogenase (tab. 4).
No significant decrease was observed in renal tissue
gentamicin concentration in rats treated with either












Standard rat chow* enriched by
CaCO3 40 g/l, Ca-gluconate 5 g/l in
Subcutaneous injection tfeatment
Twice daily saline 0.2 ml at 08.00h and
16.00 h.
Gentamicin 100 mg/kg body weight at 08.00 h
and 0.2 inl saline at 16.00 h
Twice daily saline 0.2 ml at 08.00h arid
16.00 h.
4 G + Ca = Gentamicin +
Calcium
5 V = Verapamil
6 G + V = Gentamicin +
Verapamil
drinking water.
Standard rat chow* enriched by




Gentamicin 100 mg/kg body weight at 08.00 h
and 0.2 ml saline at 16.00 h.
Verapamil 2.5 mg/kg body weight at 08.00 h
and 16.00 h.
Verapamil 2.5 mg/kg body weight at 08.00 h
and 16.00 h and gentamicin 100 mg/kg body
weight at 08.00 h.
* Calcium enrichment started 24 hours before gentamicin treatment.

































Significance P < 0.001 for gentamicin addition.
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* Significance P < 0.001, for gentamicin addition.
Tab. 4. Correlation coeffkients relating urea and creatinine val-


















Probability < 0.0001 for all these correlations.
Discussion
Nephrotoxicity is a major adverse effect of amino-
glycoside antibiotic agents. The renal dysfunction due
to gentamicin treatment in humans has been related
to several risk factors (2, 3, 15, 16). The precise
intracellular targets that are affected by these agents,
leading to renal damage are uncertain. Plasma mem-
brane and lysosomal phospholipases, basolateral
membrane Na+-K+-ATPase and mitochondrial mem-
branes have been proposed (17—20). Recently gen-
tamicin-induced decreases in mitochondrial cyto-
chrome enzyme concentrations were observed, sug-
gesting the pqssibility that the renal tubular cell pro-
tein synthetic mechanisms are disturbed by this agent
(21).
The wide use of these antibiotic agents and their major
contribution in the treatment of various infectious
prpcesses have initiated a seareh for treatment mo-
dalities which may eliminate or amelioräte their neph-
Tab. 5. Gentamicin values (mg/g protein) in renal tissue.
rotoxic effect. It has been shown that hydroxyl radical
scavengers such äs dimethylthiourea, dimethyl sul-
phoxide and sodium benzoate or deferoxamine (a
potent iron chelator) may moderate the gentamicin-
induced renal failure in rats (22).
Several investigators have dernonstrated that the
administration of calcium to rats also ameliorated
gentamicin nephrotoxicity (4 — 6). The mechanism by
which this phenomenon is achieved is unclear. It has
been suggested that calcium may act äs a competitive
inhibitor, modifying gentamicin interaction with crit-
ical subcellular membrane sites of the renal proximal
tubule (6).
In the present study the administration of gentamicin
to rats was associated with severe nephrotoxicity äs
evidenced by impairment of both kidney function
(increased urea and creatinine) and metabolism (de-
crease in various cellular enzymatic activities). In
agreement with others (4—6) a high calcium diet was
not associated with a lower gentamicin concentration
in the renal cortex. However, in contrast to previous
reports (2—4), we did not observe any significant
amelioration in the degree of nephrotoxicity. This
difference in observations can not.be explained on a
basis of different protocols. Calcium concentration in
the diet was similar to that used by others (4—6).
The time elapsing between the initiation of calcium
loading and the administration of gentamicin, and
the dosage of gentamicin were identical to those of a
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It has been shown that calcium loading in the presence
of high sodium intake-induced volume expansion,
may not be protective against renal cell injury caused
by gentamicin (6). Dietary restriction of protein intake
may also moderate to some degree aminoglycoside
nephrotoxicity (23). We did not monitor the sodium
or protein intake. It may well be that the differing
results in our study at least in part, reflect nutritional
factors.
Nephrocalcinosis is a common complication of the
uraemic state and may play a decisive role in its
Progression. Gentamicin nephrotoxicity is associated
with a significant increase in cellular calcium concen-
tration (6,24). The main site of its accumulation seems
to be within the mitochondria (24). Recently it has
been shown that verapamil, a potent calcium-channel
blocker may prevent nephrocalcinosis (7). In our
study we could not demonstrate any amelioration of
gentamicin-induced nephrotoxicity by either kidney
function indices or enzymatic-metabolic ones. The
administration of verapamil also had no effect on
renal tissue gentamicin concentration. Of special in-
terest are the significant correlations between renal
function indices such äs urea and creatinine, and
various enzyme activities. These inverse relationships,
which to the best of our knowledge have never been
reported previously, demonstrate the direct depencU
ence of glomerular filtration on enzymatic metabolic
activities.
We conclude that oral calcium supplementation dpes
not ameliorate gentamicin-induced nephrotoxicity,
unless other metabolic or nutritional factors afe
strictly controlled. Calcium channel blockers do not
prevent or moderate the gentamicin-induced renal
failure. Changes in metabolism, äs reflected by a
marked reduction in intracellular enzyme activities,
correläte significantly with the degree of gentamicin-
induced impairment in glomerular filtration.
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